Nilotinib 200 mg capsules recalled after failing appearance tests
Cipla USA is recalling one lot of Nilotinib Capsules 200 mg after out-of-specification results in description and visual appearance testing at six-month long-term stability.
- Product
- NILOTINIB — NILOTINIB (NILOTINIB)
- Category
- Drug
- Distribution
- Distributed nationwide